Concepedia

J. B. Méric

JB

Statistics

Publications

3

Citations

106

H-Index

3

Active since

2006

Affiliations

Regeneron (United States)(Current)

J. B. Méric is an author at Regeneron (United States) specializing in pharmacology, medicine, and cancer pharmacology.

Publications per year

2006–2008

3

Publications

3

Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib

Bertrand Billemont, Jacques Médioni, Laurent Taillade et al. · British Journal of Cancer · 2008 · 75 citations · Full text

, , +17

A phase I dose escalation (DE) and pharmacokinetics (PK) study of intravenous aflibercept (VEGF Trap) plus irinotecan, 5-fluorouracil, and leucovorin (I-LV5FU2) in patients with advanced solid tumors (STs)

O. Rixe, Chris Verslype, D. Khayat et al. · Journal of Clinical Oncology · 2008 · 16 citations

, , +17

Safety and pharmacokinetics of intravenous VEGF Trap plus irinotecan, 5-fluorouracil, and leucovorin (I-LV5FU2) in a combination phase I clinical trial of patients with advanced solid tumors

O. Rixe, Chris Verslype, J. B. Méric et al. · Journal of Clinical Oncology · 2006 · 15 citations

, , +8

1–3 of 3